[Management of metastatic testicular germ cell tumors]

Bull Cancer. 2019 Oct;106(10):896-902. doi: 10.1016/j.bulcan.2019.05.004. Epub 2019 Aug 26.
[Article in French]

Abstract

Metastatic testicular germ cell tumors are rare entities with a high cure rate owing to their major chemosensitivity. Current guidelines should be strictly followed to ensure maximal cure rate. Germ cell tumor treatment requires multidisciplinary skills and is based on cisplatin-based chemotherapy. The current challenge for these patients with favorable prognosis is to limit over- or under-treatment. Centralization of care for patients with these rare cancers is a key point to achieve the best chance of cure.

Keywords: Follow-up; Metastases; Stade métastatique; Testicular germ cell cancer; Traitement; Treatment; Tumeurs germinales testiculaires; suivi.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Cisplatin / therapeutic use
  • Combined Modality Therapy / methods
  • Humans
  • Male
  • Neoplasms, Germ Cell and Embryonal / classification
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Neoplasms, Germ Cell and Embryonal / secondary*
  • Neoplasms, Germ Cell and Embryonal / therapy*
  • Orchiectomy
  • Prognosis
  • Testicular Neoplasms / classification
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / secondary*
  • Testicular Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Cisplatin

Supplementary concepts

  • Testicular Germ Cell Tumor